Prayer/Spiritual Healing |
|
|
Clinical Trial: Platelets for Acute Wound Healing
This study is currently recruiting patients.
Verified by Medtronic July 2005
|
Purpose
| Condition | Intervention |
|---|---|
| Acute wounds healing by secondary intention | Device: autologous platelet gel |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Official Title: Platelets in Acute Wounds: A Punch Biopsy Study (PAWS II)
Secondary Outcomes: Measurements of wound depth at each visit. Measurement of residual scarring at 6 months post wounding.
Expected Total Enrollment: 4
Study start: July 2005; Expected completion: May 2006
Last follow-up: February 2006; Data entry closure: March 2006
Platelets contribute to the healing process in soft tissue by providing the initial hemostasis that occurs following injury, a framework for fibrin matrix formation and contribution of growth factors.
According to the US National Institute of Health, surgical procedures are considered a form of controlled injury, so many of the complications faced by surgery patients are very similar to those faced by trauma patients. Scientists are currently investigating ways to treat wounds caused by trauma, burns or surgical inventions with biological agents (i.e. growth factors) or new drugs. Growth factor priming of acute wound sites pre-activates the cellular and molecular components of tissue repair, prior to tissue injury.
Objectives are aimed at gathering information to establish evidence that autologous platelet gel positively effects the healing of acute wounds.
Eligibility
Accepts Healthy Volunteers
Inclusion Criteria: Normal volunteers, 18 years old or older -
Exclusion Criteria: Pregnant of lactating Diabetic, keloid former, collagen vascular disease Smoker Body Mass Index >30kg/m2 Know history of HIV, AIDS, Hepatitis A, B, or C Bleeding disorder, Aspirin, NSAID or anticoagulant user Cancer or treatment for cancer in past 5 years-
Location and Contact Information
Minnesota
DaVita Clinical Research, Minneapolis, Minnesota, 55404, United States; Recruiting
David Hom, M.D., Principal Investigator
David Hom, M.D., Principal Investigator, University of Minnesota
More Information
Last Updated: August 1, 2005
Record first received: July 29, 2005
ClinicalTrials.gov Identifier: NCT00125086
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-08-02

Not Signed In -

